Lisa M.

Lisa M. serves as an Associate Clinical Trial Manager at ALX Oncology since June 2023, following a role as a Clinical Research Coordinator II at Stanford University School of Medicine, where Lisa led the NIH-sponsored RECOVER Long COVID-19 clinical trial. Prior to that, Lisa worked as a Clinical Research Coordinator at SUNY Upstate Medical University Hospital, contributing to multiple Phase 3 and Phase 1 clinical studies, including the Pfizer COVID-19 Vaccine and GSK HIV Treatment studies. Lisa's experience also includes assisting in rare disease marketing campaigns at The Schwartz Group, Inc. and facilitating research studies related to headaches and naloxone at UBMD Emergency Medicine, with findings published in the Official Journal of the Society for Academic Emergency Medicine. Lisa holds both a Bachelor of Science in Biology and a Bachelor of Arts in Psychology from the University at Buffalo.